AbbVie may be working through COVID-19, but it’s pressing ahead with its Allergan merger, too—and taking stock of products […]
Gilead Sciences scored a massive win earlier this week with its first positive data readout for investigational candidate […]
At the J.P. Morgan Healthcare Conference in January—back when few could predict the looming destruction of COVID-19—Amgen CEO […]
Moderna Therapeutics has partnered with the federal government to create an mRNA-based COVID-19 vaccine it hopes to speed […]
FiercePharmaAsia—AZ’s COVID-hit China business; GSK’s $3.7B Unilever stake sale; I-Mab eyes $2B deal
AstraZeneca saw its China sales growth slow down in the first quarter, when the coronavirus outbreak was at […]
A research programme to determine the prevalence of covid-19 in the community and the proportion of the population […]
Antiviral drug remdesivir helps patients hospitalised with covid-19 recover faster and may also reduce mortality, according to the […]
NHS England has set out details of which regular services should be prioritised for resumption over the next […]
The prototype test is based on the fact that sugars coat all human cells
ATTRACT (Angiotensin II Type Two Receptor Agonist Covid-19 Trial) is targeting hospitalised patients treated with basic respiratory care, […]